This literature review evaluates the impact of restricted access to atypical antipsychotic drugs in individuals with schizophrenia or bipolar disorder.
Kimberly Boswell, MD
Advertisement
Articles by Kimberly Boswell, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
2
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
3
How Often Do Health Insurers Deny Doctor-Recommended Care?
4
Sudden Death in HFpEF Often Preceded by Clinical Decline
5